LONDON, July 7, 2026, 16:02 BST
- Iofina LON:IOF traded 4.83% higher at 54.51p as of 15:54 BST. The FTSE AIM All-Share slipped 1.09%.
- Trading volume hit 781,510 shares, around 57% higher than the average on Google Finance.
- IO#11 extra brine plus the Permian project point to about $23,000-$53,000 in reported capital spending per annual tonne.
- Iofina’s company news page did not show any new release since a director shareholding notice on June 30.
Iofina plc LON:IOF moved higher late Tuesday before the London close. Shares gained even as the AIM slipped. The quote was from a routine London session—LSE trades between 0800 and 1630 BST, with no bank holiday listed for July 7 in England and Wales.
Iofina hasn’t put out anything new since the June 30 Director/PDMR notice. Market focus is still on earlier updates: the new brine supply, low plant spending, and iodine prices above $70/kg.
| Market measure | Iofina LON:IOF | FTSE AIM All-Share |
|---|---|---|
| Latest quote | 54.51p as of 15:54 BST | 770.29 at 15:40 BST |
| Day move | up 4.83% | down 1.09% |
| Day range | traded from 51.00p to 57.00p | 770.15 to 777.16 |
| 52-week range | 20.00p to 59.00p in the past year | 693.87 to 837.43 in 52 weeks |
| Volume | 781,510 shares, average is 498,760 | not provided |
Iofina finished at 52p on July 6, according to price data from Morningstar on Intelligent Investor. That put the stock up 98.1% in 2026 at that point. Google Finance on Tuesday showed the price higher again before the market closed.
The focus for investors is shifting from scarcity of iodine to how Iofina can cut costs when it grows output. In June, the company said more brine at IO#11 should lift production by 45-65 metric tonnes of crystalline iodine per year for about $1.5 million. Iofina’s 2025 results also point to its larger Permian Basin plant with Western Midstream Partners (NYSE:WES), where it expects to add 170-220 tonnes a year; the project was listed at $8 million-$9 million.
| Capacity item | Company disclosure | Calculation from disclosed figures |
|---|---|---|
| IO#11 additional brine | About $1.5 mln for +45-65 MT/year | Capex comes in at $23,000-$33,000 per annual MT |
| Permian Basin plant | $8 mln-$9 mln for +170-220 MT/year | Capex runs $36,000-$53,000 per annual MT |
| 2025 realised iodine price | $74.02/kg | Revenue lands at $74,020 per MT before any costs or mix |
This is important since the stated capex per annual tonne is less than the revenue per tonne based on Iofina’s 2025 realised iodine price. It’s not a profit margin figure. But it points to why brine flow, plant uptime, startup timing, and iodine pricing matter more to the share price than the plant’s sticker cost.
Iofina put out 178.9 tonnes of crystalline iodine in Q1, up 44% from 124.1 tonnes the same time last year. The company raised its H1 2026 output forecast to around 385 tonnes, up from the old range of 325-355 tonnes. President and CEO Dr Tom Becker said in April Iofina was off to a “strong start to 2026” and tracking for “higher than anticipated H1 2026 production.”
The financials shifted, with revenue up 22% for 2025 at $66.5 million. Adjusted EBITDA jumped 56% to $11.8 million. Net cash, not counting lease liabilities, was $5.2 million. Sales of raw crystallised iodine climbed 42% to $35.0 million, helped by a 32% rise in volume and an 8% better realised price.
Becker said in the annual report that Iofina sees a “clear short-term pathway to exceed 1,000MT” of yearly crystalline iodine output. The company expects its Permian plant to be online in Q3 2026. Iofina also said the IO#11 brine project should wrap up in Q3. Investegate
Becker told Proactive in April the iodine market is about 40,000 metric tons and that prices tend to stay in the mid-$70s. He said the company had seen no significant impact so far from supply chain disruption.
Iofina non-executive director Tim Hughes picked up 20,003 shares at 50p each on June 29, the company said. That price is under Tuesday’s close of 54.51p.
